Clinical Challenges In Therapeutic Drug Monitoring: Special Populations, Physiological Conditions…

Paperback | May 17, 2016

byWilliam ClarkeEditorAmitava Dasgupta

not yet rated|write a review
Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics focuses on critical issues in therapeutic drug monitoring including special requirements of therapeutic drug monitoring important to special populations infants and children, pregnant women, elderly patients, and obese patients . The book also covers issues of free drug monitoring and common interferences in using immunoassays for therapeutic drug monitoring. This book is essential reading for any clinician, fellow, or trainee who wants to gain greater insight into the process of therapeutic drug monitoring for individual dosage adjustment and avoiding drug toxicity for certain drugs within a narrow therapeutic window. The book is written specifically for busy clinicians, fellows, and trainees who order therapeutic drug monitoring and need to get more familiar with testing methodologies, issues of interferences, and interpretation of results in certain patient populations. Offers busy clinicians, pathologists, and trainees a concise resource on the key aspects and critical issues in therapeutic drug monitoring Focuses on patient populations such as infants and children, pregnant women, elderly patients, and obese patients, who have special requirements in therapeutic drug monitoring Explores special topics in therapeutic drug monitoring including free drug monitoring and common immunoassay interference Explains how individual dosage adjustments can prevent drug toxicity for certain drugs within a narrow therapeutic window

Pricing and Purchase Info

$67.83 online
$68.95 list price
In stock online
Ships free on orders over $25

From the Publisher

Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics focuses on critical issues in therapeutic drug monitoring including special requirements of therapeutic drug monitoring important to special populations infants and children, pregnant women, elderly patients, and obese...

William Clarke received his PhD in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine, ending in 2002. In addition, he received an MBA focused on Medical Services Management from the Carey School of Business at Joh...

other books by William Clarke

Clarkesworld Magazine Issue 91
Clarkesworld Magazine Issue 91

Kobo ebook|Apr 1 2014

$3.92

Imaging in Endocrinology
Imaging in Endocrinology

Kobo ebook|Oct 14 2013

$123.99

see all books by William Clarke
Format:PaperbackDimensions:376 pages, 8.75 × 6.35 × 0.68 inPublished:May 17, 2016Publisher:Elsevier Science & TechLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0128020253

ISBN - 13:9780128020258

Look for similar items by category:

Customer Reviews of Clinical Challenges In Therapeutic Drug Monitoring: Special Populations, Physiological Conditions And Pharmacogenomics: Special Populations, Physiolog

Reviews

Extra Content

Table of Contents

Overview of Therapeutic Drug Monitoring

Immunoassays and Issues with Interference in Therapeutic Drug Monitoring

Application of Chromatography Combined with Mass Spectrometry in Therapeutic Drug Monitoring

Clinical Utility of Free Drug Monitoring

Therapeutic Drug Monitoring of Newer Antiepileptic Drugs

Therapeutic Drug Monitoring of Antiretrovirals

Therapeutic Drug Monitoring in Infants and Children

Therapeutic Drug Monitoring in Pregnancy

Therapeutic Drug Monitoring in the Elderly

Therapeutic Drug Monitoring in Obese Patients

Special Issues in Therapeutic Drug Monitoring in Patients with Uremia, Liver Disease, and Critically Ill Patients

Integrating Therapuetic Drug Monitoring and Pharmacogenomics

Warfarin Pharmacogenomics

Drug Monitoring in Alternative Matrices

Integrating and Supporting Therapeutic Drug Monitoring in a Hospital System